Jennifer Le Guevelou

Oncology-Radiotherapy
Eugène Marquis Center
Rennes, France
jennifer.leguevelou@gmail.com

Dr. Jennifer Le Guévelou is currently a PhD student in University of Rennes, France.

Her training included residency in Normandy, France, where she developed head and neck guidelines, and expertise in protontherapy and brachytherapy.

She performed a fellowship in Geneva, under the guidance of Prof. Thomas Zilli, where she worked on projects including combined hyperthermia and prostate cancer radiotherapy, and the place of SBRT in the management of renal cell carcinoma.

Her primary interest is in genito-urinary oncology, and especially the management of prostate at both an early and metastatic stage. In the past few years, she focused on optimization of treatment planning for prostate cancer radiotherapy, by developing several approaches such as urinary-organs-at risk sparing, and dose-escalation on the dominant intraprostatic lesion (DIL). She is currently the leader of the phase III trial ORION, supported by the GETUG group, assessing the place of dose-escalation on the DIL for patients with high-risk prostate cancer. She is also one of the co-leaders of the prospective meta-analysis FLAMENCO, that will include both Hypoflame3.0, Hypofocal SBRT and ORION trials.

She is also a researcher in head and neck oncology, focusing on both early detection strategies, reduction of toxicity following radiotherapy, and implementation of SBRT in specific disease settings.

Last but not least, her interest includes the management of cancer occurring during pregnancy, both with respect to head and neck and gynecological tumors.